Literature DB >> 8658522

Elevated sphingoid bases and complex sphingolipid depletion as contributing factors in fumonisin-induced cytotoxicity.

H S Yoo1, W P Norred, J Showker, R T Riley.   

Abstract

Fumonisin B1 is an inhibitor of ceramide synthase, a key enzyme in de novo sphingolipid biosynthesis and reacylation of free sphingosine. The purpose of this study was to determine the contribution of increased intracellular free sphinganine and decreased complex sphingolipids on cell growth and cell death induced by fumonisin B1 in pig kidney LLC-PK1 cells. Fumonisin B1 caused an increase in intracellular free sphinganine which preceded depletion of complex sphingolipids, inhibition of cell growth, and cell death. The effects on cell growth and cell death were well correlated with the increase in free sphingoid bases and depletion of complex sphingolipids. Exogenously added sphinganine mimicked the effects of fumonisin, but beta-chloroalanine, an inhibitor of serine palmitoyltransferase which is the first enzyme in de novo sphingolipid biosynthesis, also inhibited cell growth and increased cell death. When added simultaneously, beta-chloroalanine reduced the fumonisin-induced sphinganine increase by approximately 90%; however, it exacerbated the decrease in more complex sphingolipids. The effects of fumonisin on cell growth and cell death were only partially prevented by beta-chloroalanine (approximately 50 to 60%). The results suggest that both the elevation of free sphingoid bases and the decrease in complex sphingolipids contribute to the decreased cell growth and cytolethality of fumonisin B1 in pig kidney LLC-PK1 cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8658522     DOI: 10.1006/taap.1996.0119

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  17 in total

1.  Screening of fungal species for fumonisin production and fumonisin-like disruption of sphingolipid biosynthesis.

Authors:  W P Norred; C W Bacon; R T Riley; K A Voss; F I Meredith
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

2.  Risk-assessment implications of mechanistic model's prediction of low-dose nonlinearity of liver tumor risk for mice fed fumonisin b(1).

Authors:  Ralph L Kodell; Angelo Turturro
Journal:  Nonlinearity Biol Toxicol Med       Date:  2004-01

3.  Distinct generation, pharmacology, and distribution of sphingosine 1-phosphate and dihydrosphingosine 1-phosphate in human neural progenitor cells.

Authors:  Phillip Callihan; Nicholas C Zitomer; Michael V Stoeling; Perry C Kennedy; Kevin R Lynch; Ronald T Riley; Shelley B Hooks
Journal:  Neuropharmacology       Date:  2011-10-15       Impact factor: 5.250

4.  Short-term Mg deficiency upregulates protein kinase C isoforms in cardiovascular tissues and cells; relation to NF-kB, cytokines, ceramide salvage sphingolipid pathway and PKC-zeta: hypothesis and review.

Authors:  Burton M Altura; Nilank C Shah; Gatha J Shah; Aimin Zhang; Wenyan Li; Tao Zheng; Jose Luis Perez-Albela; Bella T Altura
Journal:  Int J Clin Exp Med       Date:  2014-01-15

5.  Simulation of fungal-mediated cell death by fumonisin B1 and selection of fumonisin B1-resistant (fbr) Arabidopsis mutants.

Authors:  J M Stone; J E Heard; T Asai; F M Ausubel
Journal:  Plant Cell       Date:  2000-10       Impact factor: 11.277

6.  DNA damage in astrocytes exposed to fumonisin B1.

Authors:  F Galvano; A Campisi; A Russo; G Galvano; M Palumbo; M Renis; M L Barcellona; J R Perez-Polo; A Vanella
Journal:  Neurochem Res       Date:  2002-04       Impact factor: 3.996

7.  In vivo effects of fumonisin B1-producing and fumonisin B1-nonproducing Fusarium moniliforme isolates are similar: fumonisins B2 and B3 cause hepato- and nephrotoxicity in rats.

Authors:  K A Voss; R D Plattner; R T Riley; F I Meredith; W P Norred
Journal:  Mycopathologia       Date:  1998       Impact factor: 2.574

8.  Effects of aflatoxin B(1) and fumonisin B(1) on the viability and induction of apoptosis in rat primary hepatocytes.

Authors:  Deise H B Ribeiro; Fabiane L Ferreira; Valéria N da Silva; Simone Aquino; Benedito Corrêa
Journal:  Int J Mol Sci       Date:  2010-04-26       Impact factor: 5.923

9.  Ceramide synthase inhibition by fumonisin B1 causes accumulation of 1-deoxysphinganine: a novel category of bioactive 1-deoxysphingoid bases and 1-deoxydihydroceramides biosynthesized by mammalian cell lines and animals.

Authors:  Nicholas C Zitomer; Trevor Mitchell; Kenneth A Voss; Genevieve S Bondy; Sarah T Pruett; Ethel C Garnier-Amblard; Lanny S Liebeskind; Hyejung Park; Elaine Wang; M Cameron Sullards; Alfred H Merrill; Ronald T Riley
Journal:  J Biol Chem       Date:  2008-12-18       Impact factor: 5.157

10.  Analysis of fumonisin B1-induced apoptosis.

Authors:  C Jones; J R Ciacci-Zanella; Y Zhang; G Henderson; M Dickman
Journal:  Environ Health Perspect       Date:  2001-05       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.